EV Biologics Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Public

  • Employees
  • 284


  • Stock Symbol
  • YECO

Stock Symbol

  • Share Price
  • $0.56
  • (As of Thursday Closing)

EV Biologics General Information


EV Biologics Inc is developing the extraordinary biological properties of extracellular vesicles (EVs) to create the next generation of diagnostic modalities and safe, effective biotherapeutics to improve outcomes of serious clinical conditions, increase natural longevity and transform lives.

Contact Information

Formerly Known As
Yulong Eco-Materials
Ownership Status
Publicly Held
Financing Status
Primary Industry
Other Industries
Drug Discovery
Stock Exchange
Corporate Office
  • 1621 Central Avenue
  • Cheyenne, WY 82001
  • United States
+1 (206) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EV Biologics Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.56 $0.55 $0.55 - $1.95 $5.68M 10.2M 1.09K

EV Biologics Financials Summary

In Thousands,
TTM 31-Dec-2017 FY 2017 30-Jun-2017 FY 2016 30-Jun-2016 FY 2015 30-Jun-2015
EV 15,043 6,095 474 66,110
Revenue 9,507 42,644 46,230
EBITDA 42,748 (5,884) (46,697) 14,557
Net Income 45,209 (7,430) (53,190) 8,680
Total Assets 58,954 33,278 36,443 77,598
Total Debt 6,469 10,347 9,765 12,726
Public Fundamental Data provided by Morningstar, Inc. disclaimer

EV Biologics Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore EV Biologics‘s full profile, request access.

Request a free trial

EV Biologics Executive Team (8)

Name Title Board Seat Contact Info
Yulong Zhu Chief Executive Officer & Chairman of the Board
Hoi Chan Chief Operating Officer & President
Monte Fisher Chief Financial Officer
Shuai Wang Chief Financial Officer, Finance
Jason Sanders Chief Medical Officer
You’re viewing 5 of 8 executive team members. Get the full list »

EV Biologics Board Members (6)

Name Representing Role Since
0000000 00 EV Biologics Board Member 000 0000
00000 000 EV Biologics Board Member 000 0000
000000000 000 EV Biologics Board Member 000 0000
00000 00 EV Biologics Board Member 000 0000
0000 00 EV Biologics Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

EV Biologics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EV Biologics FAQs

  • When was EV Biologics founded?

    EV Biologics was founded in 2011.

  • Who is the CEO of EV Biologics?

    Yulong Zhu and Daniel Mckinney are the CEOs of EV Biologics.

  • Where is EV Biologics headquartered?

    EV Biologics is headquartered in Cheyenne, WY.

  • What is the size of EV Biologics?

    EV Biologics has 284 total employees.

  • What industry is EV Biologics in?

    EV Biologics’s primary industry is Biotechnology.

  • Is EV Biologics a private or public company?

    EV Biologics is a Public company.

  • What is EV Biologics’s stock symbol?

    The ticker symbol for EV Biologics is YECO.

  • What is the current stock price of EV Biologics?

    As of 23-May-2024 the stock price of EV Biologics is $0.56.

  • What is the current market cap of EV Biologics?

    The current market capitalization of EV Biologics is $5.68M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »